The FDA has approved the first skin patch to treat attention deficit hyperactivity disorder in children. It contains methylphenidate, which is the same stimulant that is in Ritalin. It is designed to be worn for 9 hours. (USATODAY.com)

June 30, 2005

The FDA said today it plans to strengthen the warning label for Concerta, the popular long-acting version of Ritalin (methylpenidate) in response to reports of psychiatric and cardiovascular adverse effects. (MedPage Today)

Posted by news editor | Filed under: ADD/ADHD

March 25, 2005

"Abbott Laboratories said Thursday that it is pulling its attention deficit disorder drug Cylert from the market, following a consumer group’s charge that the drug caused serious and sometimes fatal health problems during its 30-year history."

Posted by news editor | Filed under: ADD/ADHD